Posts by: Joana Carvalho

News

A population-based pharmacokinetic approach for tailored treatment regimens of hemophilia A patients may contribute to an increase in treatment adherence and a decrease in annual bleeding episodes, a study shows. The ... Read more

March 11, 2019March 11, 2019

Erectile Dysfunction More Prevalent with Age in Men With Hemophilia, Study Says

News

Erectile dysfunction, more commonly known as male impotence, is associated with older age in men with hemophilia, especially those who smoked long term and have high blood pressure, a study ... Read more

March 1, 2019March 1, 2019

Scientists Combine CRISPR-Cas9, Adenovirus Gene Delivery to Restore Function of FIX in Mice

News

Scientists successfully combined the gene-editing tool CRISPR-Cas9 and a special type of virus to deliver corrected genes to restore the function of the coagulation factor IX (FIX) gene in ... Read more

February 4, 2019February 4, 2019

Research into Physiotherapy and Rehab for Hemophilia Patients Needed, Review Says

News

People with hemophilia may benefit from physiotherapy and rehabilitation programs intended to manage bleeding and joint disease (arthropathy), but more research is needed to better understand those programs — and ... Read more

February 1, 2019February 1, 2019

Study Finds No Differences in Oral Health Quality of Life in Children With Hemophilia

News

Despite having lower oral health scores, children with hemophilia showed no differences in oral health-related quality of life compared to children without the condition, a study found. The study, “Parent’s report ... Read more

January 23, 2019January 23, 2019

ISTH-BAT Is Useful to Identify, Assess Hemophilia Patients, Study Suggests

News

The International Society on Thrombosis and Hemostasis (ISTH) created a Bleeding Assessment Tool (BAT) that is useful to identify and assess disease severity in people with hemophilia, both newly diagnosed patients and those who ... Read more

January 7, 2019January 7, 2019

Novoeight Safe, Effective in Hemophilia A Patients Over Long Term, Phase 3b Trial Shows

News

Long-term treatment with Novoeight (turoctocog alfa) is safe and effective at preventing bleeding episodes in patients with hemophilia A of all ages who had already received prior treatment, a Phase ... Read more

January 2, 2019January 11, 2019

Catalyst Announces Updates on Two Lead Compounds for Hemophilia

News

Catalyst Biosciences recently announced updates on two of its lead compounds — Factor VIIa (FVIIa) marzeptacog alfa (activated) (MarzAA) and Factor IX (FIX) dalcinonacog alfa (DalcA) — for treatment of hemophilia A or B with inhibitors, and ... Read more

December 19, 2018December 19, 2018

Preventive Use of Idelvion Lets Kids with Hemophilia B Need Fewer Infusions, Trial Shows

News

Prophylaxis with Idelvion (rIX‐FP) significantly improved clinical outcomes and quality of life for children with hemophilia B and eased daily life for their caregivers, Phase 3 clinical trial data ... Read more

November 30, 2018November 30, 2018

Bayer Announces the Approval of Jivi for Hemophilia A in Europe

News

Jivi (BAY94-9027), a lab-made version of the blood clotting factor VIII (FVIII), has been approved by the European Commission for the prophylactic (preventative) treatment of hemophilia A in patients older ... Read more

Posts by: Joana Carvalho

Joana Carvalho

Population-Based Pharmacokinetic Dosing May Benefit Hemophilia A Patients, Study Reports

Erectile Dysfunction More Prevalent with Age in Men With Hemophilia, Study Says

Scientists Combine CRISPR-Cas9, Adenovirus Gene Delivery to Restore Function of FIX in Mice

Research into Physiotherapy and Rehab for Hemophilia Patients Needed, Review Says

ISTH-BAT Is Useful to Identify, Assess Hemophilia Patients, Study Suggests

Novoeight Safe, Effective in Hemophilia A Patients Over Long Term, Phase 3b Trial Shows

Catalyst Announces Updates on Two Lead Compounds for Hemophilia

Preventive Use of Idelvion Lets Kids with Hemophilia B Need Fewer Infusions, Trial Shows

Bayer Announces the Approval of Jivi for Hemophilia A in Europe

Pin It on Pinterest